Evidence map›Paper›PMID 31387267›Full record

ReviewPharmaceutics2019

BMP-2 Gene Delivery-Based Bone Regeneration in Dentistry.

Shin-Young Park, Kyoung-Hwa Kim, Sungtae Kim, Yong-Moo Lee, Yang-Jo Seol

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Antisolvent 3D Printing of Gene-Activated Scaffolds for Bone Regeneration.International journal of molecular sciences · 2024
    Article
  14. Review
  15. Biodegradable poly(caprolactone fumarate) 3D printed scaffolds for segmental bone defects within the Masquelet technique.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Chemically heparinized PEEKRSC advances · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shin-Young ParkProgram of Clinical Dental Education and Dental Research Institute, School of Dentistry, Seoul National University, Seoul 03080, Korea.
Kyoung-Hwa KimDepartment of Periodontology and Dental Research Institute, School of Dentistry, Seoul National University, Seoul 03080, Korea.
Sungtae KimDepartment of Periodontology and Dental Research Institute, School of Dentistry, Seoul National University, Seoul 03080, Korea.
Yong-Moo LeeDepartment of Periodontology and Dental Research Institute, School of Dentistry, Seoul National University, Seoul 03080, Korea.ORCID 0000-0002-5619-3847
Yang-Jo SeolDepartment of Periodontology and Dental Research Institute, School of Dentistry, Seoul National University, Seoul 03080, Korea. yjseol@snu.ac.kr.ORCID 0000-0002-2076-5452
Seoul National University · KR

Funding

Ministry of Education, Republic of Korea (2016R1C1B2016624, 2017R1D1A1B03033244)
6 · The paper itself

Abstract

Bone morphogenetic protein-2 (BMP-2) is a potent growth factor affecting bone formation. While recombinant human BMP-2 (rhBMP-2) has been commercially available in cases of non-union fracture and spinal fusion in orthopaedics, it has also been applied to improve bone regeneration in challenging cases requiring dental implant treatment. However, complications related to an initially high dosage for maintaining an effective physiological concentration at the defect site have been reported, although an effective and safe rhBMP-2 dosage for bone regeneration has not yet been determined. In contrast to protein delivery, BMP-2 gene transfer into the defect site induces BMP-2 synthesis in vivo and leads to secretion for weeks to months, depending on the vector, at a concentration of nanograms per milliliter. BMP-2 gene delivery is advantageous for bone wound healing process in terms of dosage and duration. However, safety concerns related to viral vectors are one of the hurdles that need to be overcome for gene delivery to be used in clinical practice. Recently, commercially available gene therapy has been introduced in orthopedics, and clinical trials in dentistry have been ongoing. This review examines the application of BMP-2 gene therapy for bone regeneration in the oral and maxillofacial regions and discusses future perspectives of BMP-2 gene therapy in dentistry.

Indexed as

animal experimentationbone morphogenetic protein 2bone regenerationgene transfer technique

Identifiers

PMID31387267
PMCPMC6723260
OpenAlexW2964766394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.